Are We There Yet? How and When Specific Biotechnologies Will Improve Human Health
Author(s)O'Day, Elizabeth; Hosta-Rigau, Leticia; Oyarzún, Diego A.; Okano, Hideyuki; de Lorenzo, Víctor; von Kameke, Conrad; Alsafar, Habiba; Cao, Cong; Chen, Guo-Qiang; Ji, Weizhi; Roberts, Richard J.; Ronaghi, Mostafa; Yeung, Karen; Zhang, Feng; Lee, Sang Yup; ... Show more Show less
MetadataShow full item record
Patient X: A 67-year-old Caucasian man slips on a patch of ice. He has abrasions to his hands and has sustained significant damage to his hip. At the emergency room, he informs clinicians he takes atorvastatin, metformin, and glimepiride to treat hypertension and Type 2 Diabetes Mellitus (T2DM). X-rays reveal a fractured hip, which will require total hip replacement surgery.
DepartmentMcGovern Institute for Brain Research at MIT; Massachusetts Institute of Technology. Department of Brain and Cognitive Sciences; Massachusetts Institute of Technology. Department of Biological Engineering
O'Day, Elizabeth et al. "Are We There Yet? How and When Specific Biotechnologies Will Improve Human Health." Biotechology Journal 14, 1 (January 2019): 1800195 © 2018 WILEY-VCH Verlag GmbH & Co.
Author's final manuscript